Haemonetics Corp Bottom Line Climbs In Q2

Published 2 days ago Positive
Haemonetics Corp Bottom Line Climbs In Q2
Auto
(RTTNews) - Haemonetics Corp (HAE) revealed a profit for its second quarter that Increases, from last year

The company's bottom line came in at $38.68 million, or $0.81 per share. This compares with $33.83 million, or $0.66 per share, last year.

Excluding items, Haemonetics Corp reported adjusted earnings of $60.30 million or $1.27 per share for the period.

The company's revenue for the period fell 5.3% to $327.32 million from $345.51 million last year.

Haemonetics Corp earnings at a glance (GAAP) :

-Earnings: $38.68 Mln. vs. $33.83 Mln. last year. -EPS: $0.81 vs. $0.66 last year. -Revenue: $327.32 Mln vs. $345.51 Mln last year.

-Guidance: Full year EPS guidance: $4.80 - $5.00

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.